Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT00083694
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of refractory or relapsed leukemia: acute leukemia, CML, CLLm and MDS.
* Signed informed consent, including patient agreeing to use safe contraceptive methods during the treatment and for at least 4 months after the treatment is completed
* Serum creatinine \< or = 2.5mg/dL
* Serum bilirubin\< or = 2.5mg/dL
* Negative pregnancy test
* Age 18 years or older
* Performance status \< or = 3
Exclusion Criteria:
* Pregnant or lactating women
* Concurrent treatment with cytotoxic chemotherapy, or radiation
* History of seizures, neurotoxicity, or active CNS disease
* Serious infections not controlled by antibiotics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00083694
Study Brief:
Protocol Section:
NCT00083694